DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock
$6,78
Preço · Ago 18, 2026
Fundamentais a partir de Ago 6, 2026
Intervalo 52 Semanas
$5–$18
12% of range
Classificação do Analista
SELL
10 analysts
Preço-Alvo
$7
+3% upside
P/E (TTM)
-1.3
ROE
-55.8%
Margem de Lucro Líquido
-183.8%
Sobre Ginkgo Bioworks Holdings, Inc. Class A Common Stock Visão geral da empresa da Wikipedia
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
Ler mais
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
History
In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program.
On 16 December 2020, it was reported that Ginkgo Bioworks would acquire the primary assets of Novogy's Microbial Engineering Platform. 2020 also saw the company acquire property worth $25 million from Marcus Partners for the construction of a new 219,000 square foot laboratory building, after razing existing structures, located in the Raymond L Flynn Marine Park. As of 2021, the company also occupied 200,000 square feet of the Innovation and Design Building (aka IDB) in the Park. Ginkgo also occupied facilities in Cambridge, where most MIT-spin outs resided at the time.
Growth of Ginkgo up to 2021 had been driven by "robust venture capital funding" and entry into the COVID-19 testing market. This included $45 million from Viking Global in 2015.
On 11 May 2021, Ginkgo Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.
On 14 May 2021, Ginkgo announced its new ticker for the NYSE will be "DNA". The ticker was previously used by Genentech, who stopped using the ticker after they were acquired by Roche. Trading began on September 17, 2021. The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022.
On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.
On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from real-time metabolite monitoring company, Bitome.
On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal.
On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. The deal includes the integration of the R&D platform assets from Joyn Bio, a joint-venture between Leaps by Bayer investments and Ginkgo Bioworks.
On 4 October 2022, it was reported that Ginkgo Bioworks would acquire France-based adaptive laboratory evolution instruments developer Altar and California-based Circularis to strengthen capabilities in cell and gene therapy.
In October 2022, Bloomberg News reported that Ginkgo Bioworks partnered with Intelligence Advanced Research Projects Activity to create a software tool to help detect when biological organisms have been genetically engineered. The tool known as ENDAR (short for Engineered Nucleotide Detection and Ranking) could be used to provide an early warning of bioweapons and other man-made biological threats.
Fraud allegations
On 6 October 2021, a market research firm published a report accusing Ginkgo of embellishing its revenue in a complex scheme highly dependent on related-party transactions. The report prompted an inquiry into Ginkgo by the United States Department of Justice. In November 2021, Ginkgo was sued in a shareholder lawsuit alleging it misrepresented its revenue sources in statements regarding its merger with a special-purpose acquisition company. As of 2021, the company could not name a single significant product that is manufactured and sold using its organisms.
In March 2023, the former Attorney General of Louisiana launched an investigation into the officers and directors of Ginkgo.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
DNA Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$6.78
Capitalização de Mercado
$418M
P/E (TTM)
-1.3
EPS (TTM)
$-5.64
Receita (TTM)
$170M
Rendimento div.
—
ROE
-55.8%
Dívida/Capital
—
Intervalo 52 Semanas
$5 – $18
DNA Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$170M
2019-12-31
→
2025-12-31
EPS
$-5.64
2019-12-31
→
2025-12-31
Fluxo de caixa livre
$-179M
2022-12-31
→
2025-12-31
Margens
-183.8%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
DNA
Mediana de Pares
P/E (TTM)
-1.3
17.5
P/S (TTM)
2.5
3.3
P/B
0.8
2.1
Price / FCF (Preço / FCF)
-2.3
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
DNA
Mediana de Pares
Operating Margin (Margem Operacional)
-185.3%
—
Net Profit Margin (Margem de Lucro Líquido)
-183.8%
-56.5%
ROA
-25.1%
-17.2%
ROE
-55.8%
-41.3%
ROIC
-61.8%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
DNA
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
4.9
4.9
Quick Ratio (Índice de Liquidez Seca)
4.7
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
DNA
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-25.1%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-29.1%
—
Revenue CAGR 5Y (CAGR Receita 5A)
17.3%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
DNA
Mediana de Pares
DNA Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
VENDA
10 analistas
- Compra forte 0 0,0%
- Compra 1 10,0%
- Manter 2 20,0%
- Venda 5 50,0%
- Venda forte 2 20,0%
Preço-alvo de 12 meses
2 analistas · 2026-08-15
Mediana
$7.00
Agora
$6.78
Mín
$5.00
Máx
$9.00
Alvo mediano
$7.00
+3,3%
Alvo médio
$7.00
+3,3%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.05%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-0.75 | $-0.92 | 0.17% |
| 31 de Março de 2026 | $-1.39 | $-1.09 | -0.30% |
| 31 de Dezembro de 2025 | $-1.41 | $-1.47 | 0.06% |
| 30 de Setembro de 2025 | $-1.45 | $-1.25 | -0.20% |
| 30 de Junho de 2025 | $-1.10 | $-1.58 | 0.48% |
| 31 de Março de 2025 | $-1.68 | $-1.79 | 0.11% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | — | — | — | — | — | — |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 15
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $227M | $251M | $478M | $314M | $77M | $54M | |
| R&D Expense | $244M | $424M | $581M | $1.05B | $1.15B | $160M | $96M | |
| SG&A Expense | $183M | $246M | $385M | $1.43B | $863M | $38M | $29M | |
| Operating Expenses | $485M | $787M | $1.12B | $2.69B | $2.14B | $214M | $126M | |
| Operating Income | $-315M | $-560M | $-864M | $-2.21B | $-1.83B | $-137M | $-72M | |
| Interest Expense | · | · | $93.0K | $106.0K | $2M | $2M | $2M | |
| Other Non-op | $2M | $12M | $-29M | $88M | $-10M | $12M | · | |
| Pretax Income | $-314M | $-548M | $-893M | $-2.12B | $-1.84B | $-125M | $-120M | |
| Income Tax | $-837.0K | $-479.0K | $-71.0K | $-15M | $-1M | $2M | $22.0K | |
| Net Income | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | $-127M | $-119M | |
| EPS (Basic) | $-5.64 | $-10.54 | $-18.37 | $-50.15 | $-1.35 | $-0.10 | $-0.10 | |
| EPS (Diluted) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | $-0.10 | $-0.10 | |
| Shares (Basic) | 55,457,676 | 51,894,639 | 48,610,507 | 41,976,537 | 1,359,849,000 | 1,274,766,915 | 1,149,000,417 | |
| Shares (Diluted) | 55,457,676 | 51,894,639 | 48,610,507 | 41,995,972 | 1,360,373,000 | 1,274,766,915 | 1,149,000,417 | |
| EBITDA | $-315M | $-560M | $-864M | $-2.21B | · | · | · |
Balanço Patrimonial 28
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $562M | $944M | $1.32B | $1.55B | $381M | $495M | |
| Short-term Investments | $255M | $0 | · | · | · | · | · | |
| Receivables | $24M | $22M | $17M | $81M | $132M | $17M | · | |
| Inventory | · | · | $46.0K | $4M | $3M | $3M | · | |
| Prepaid Expense | $25M | $19M | $40M | $52M | $34M | $21M | · | |
| Other Current Assets | · | · | $362.0K | $487.0K | $698.0K | $680.0K | · | |
| Current Assets | $472M | $603M | $1.00B | $1.45B | $1.72B | $427M | · | |
| PP&E (Net) | $167M | $204M | $188M | $315M | $146M | $121M | · | |
| PP&E (Gross) | $355M | $365M | $309M | $408M | $207M | $155M | · | |
| Accum. Depreciation | $188M | $161M | $121M | $93M | $61M | $34M | · | |
| Goodwill | · | $0 | $49M | $60M | $21M | $2M | $2M | |
| Intangibles | $53M | $73M | $83M | $111M | $22M | $3M | · | |
| Other Non-current Assets | $9M | $55M | $58M | $89M | $44M | $6M | · | |
| Total Assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Accounts Payable | $11M | $14M | $9M | $10M | $8M | $14M | · | |
| Accrued Liabilities | · | · | · | $115M | $93M | $31M | · | |
| Short-term Debt | · | · | · | · | · | $300.0K | · | |
| Current Liabilities | $96M | $107M | $164M | $173M | $135M | $73M | · | |
| Capital Leases | $417M | $439M | $222M | $413M | $0 | · | · | |
| Other Non-current Liabilities | $23M | $17M | $24M | $31M | $36M | $3M | · | |
| Total Liabilities | $611M | $661M | $568M | $803M | $504M | $205M | · | |
| Common Stock | $6.0K | $5.0K | $5.0K | $190.0K | $161.0K | $129.0K | · | |
| Paid-in Capital | $6.66B | $6.56B | $6.39B | $6.14B | $3.80B | $929M | · | |
| Retained Earnings | $-6.15B | $-5.84B | $-5.29B | $-4.40B | $-2.30B | $-468M | · | |
| AOCI | $2M | $-2M | $1M | $-3M | $-2M | $0 | · | |
| Stockholders' Equity | $509M | $716M | $1.10B | $1.74B | $1.57B | $470M | · | |
| Liabilities + Equity | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Shares Outstanding | 58,207,298 | 54,365,785,000 | 50,032,873 | 47,299,399 | 40,284,804 | 1,288,596,000 | · |
Fluxo de Caixa 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $59M | $63M | $71M | $43M | $29M | $14M | $11M | |
| Stock-based Comp | $82M | $112M | $230M | $1.93B | $1.61B | $476.0K | $771.0K | |
| Deferred Tax | $-1M | $-936.0K | $-801.0K | $-15M | $0 | $0 | · | |
| Amort. of Intangibles | $19M | $18M | $16M | $6M | $1M | $500.0K | $500.0K | |
| Restructuring | $11M | $19M | · | · | · | · | · | |
| Operating Cash Flow | $-171M | $-320M | $-296M | $-252M | $-254M | $-136M | $-45M | |
| CapEx | $8M | $63M | $41M | $52M | $57M | $58M | $22M | |
| Investing Cash Flow | $-240M | $-62M | $-81M | $-67M | $-73M | $-67M | $-75M | |
| Stock Issued | $19M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | $408.0K | |
| Net Stock Activity | $19M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $-2M | $-3M | $95M | $1.53B | $90M | $410M | |
| Net Change in Cash | $-393M | $-384M | $-380M | $-223M | $1.21B | $-113M | $291M | |
| Taxes Paid | $192.0K | $0 | $23.0K | $981.0K | $9M | $0 | · | |
| Free Cash Flow | $-179M | $-382M | $-336M | $-304M | · | · | · | |
| Levered FCF | · | · | $-336M | $-305M | · | · | · |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| Net Margin | -183.8% | -240.9% | -355.1% | -440.6% | · | · | · | |
| Pretax Margin | -184.3% | -241.2% | -355.1% | -444.1% | · | · | · | |
| EBITDA Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| ROA | -25.1% | -36.0% | -42.5% | -91.3% | · | · | · | |
| ROE | -55.8% | -72.3% | -76.0% | -132.4% | · | · | · | |
| ROIC | -61.8% | -78.1% | -78.8% | -126.3% | · | · | · |
Liquidez e Solvência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.6 | 6.1 | 8.4 | · | · | · | |
| Quick Ratio | 4.7 | 5.4 | 5.9 | 8.1 | · | · | · | |
| Interest Coverage | · | · | -9294.7 | -20839.2 | · | · | · |
Eficiência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | |
| Receivables Turnover | 7.4 | 11.6 | 5.1 | 4.5 | · | · | · |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -25.1% | -9.7% | -47.4% | 52.2% | 309.4% | · | · | |
| Revenue CAGR 3Y | -29.1% | -10.2% | 48.6% | · | · | · | · | |
| Revenue CAGR 5Y | 17.3% | · | · | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $227M | $251M | $478M | $314M | · | · | |
| Net Income TTM | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | · | · | |
| Market Cap | $484M | $534M | $135.29B | $127.90B | · | · | · | |
| P/E | -1.5 | -0.9 | -3.7 | -1.3 | -239.1 | · | · | |
| P/S | 2.8 | 2.4 | 538.0 | 267.7 | · | · | · | |
| P/B | 1.0 | 0.7 | 123.3 | 73.7 | · | · | · | |
| P / Tangible Book | 1.1 | 0.8 | 140.2 | 81.7 | 351.4 | · | · | |
| P / Cash Flow | -2.8 | -1.7 | -457.8 | -507.1 | · | · | · | |
| P / FCF | -2.7 | -1.4 | -402.3 | -420.1 | · | · | · | |
| Earnings Yield | -67.9% | -107.3% | -27.2% | -74.3% | -0.42% | · | · |
Demonstração de Resultados 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | $19M | $33M | $39M | $39M | $38M | $44M | $89M | $56M | $38M | $35M | $55M | $81M | $81M | $98M | $66M | |
| Cost of Revenue | $2M | $3M | · | · | $5M | $4M | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $46M | $50M | $50M | $69M | $53M | $71M | $76M | $77M | $134M | $136M | $117M | $157M | $144M | $163M | $178M | $261M | |
| SG&A Expense | $31M | $38M | $46M | $45M | $35M | $40M | $57M | $52M | $66M | $70M | $89M | $82M | $102M | $111M | $121M | $435M | |
| Operating Expenses | $79M | $91M | $104M | $129M | $97M | $119M | $147M | $144M | $279M | $216M | $213M | $342M | $265M | $296M | $329M | $721M | |
| Operating Income | $-59M | $-71M | $-71M | $-90M | $-58M | $-81M | $-104M | $-55M | $-223M | $-178M | $-178M | $-286M | $-184M | $-216M | $-231M | $-655M | |
| Other Non-op | $1M | $-5M | $-11M | $9M | $5M | $-2M | $-4M | $-2M | $6M | $12M | $-34M | $-17M | $11M | $11M | $43M | $-15M | |
| Pretax Income | $-57M | $-76M | $-81M | $-81M | $-53M | $-83M | $-108M | $-57M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-188M | $-670M | |
| Income Tax | $128.0K | $-80.0K | $-643.0K | $1.0K | $-283.0K | $88.0K | $-325.0K | $-375.0K | $190.0K | $31.0K | $-198.0K | $-22.0K | $67.0K | $82.0K | $-15M | $-28.0K | |
| Net Income | $-47M | $-83M | $-81M | $-81M | $-60M | $-91M | $-108M | $-56M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-175M | $-670M | |
| EPS (Basic) | $-0.75 | $-1.39 | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.92 | $-1.08 | $-4.23 | $-3.31 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-48.96 | $-0.41 | |
| EPS (Diluted) | · | · | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.91 | $-1.08 | $-4.23 | $-3.32 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-49.01 | $-0.41 | |
| Shares (Basic) | 62,094,356 | 59,563,454 | -109,276,643 | 55,633,718 | 54,858,982 | 54,241,619 | -101,827,409 | 52,240,559 | 51,370,029 | 50,111,460 | -3,848,559,493 | 48,770,000 | 1,933,437,000 | 1,914,963,000 | -3,211,245,963 | 1,630,911,000 | |
| Shares (Diluted) | · | · | -109,276,643 | 55,633,718 | 54,858,982 | 54,241,619 | -101,860,455 | 52,246,129 | 51,375,599 | 50,133,366 | -3,850,233,493 | 48,770,000 | 1,933,437,000 | 1,916,637,000 | -3,211,226,528 | 1,630,911,000 | |
| EBITDA | $-59M | $-71M | · | $-90M | $-66M | $-89M | · | $-55M | $-223M | $-178M | · | $-286M | $-184M | $-216M | · | $-653M |
Balanço Patrimonial 25
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $144M | $167M | $111M | $204M | $312M | $562M | $616M | $730M | $840M | $944M | $1.05B | $1.11B | $1.21B | $1.32B | $1.30B | |
| Short-term Investments | · | · | $255M | $384M | $356M | $13M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | $13M | $20M | $24M | $21M | $22M | $26M | $22M | $23M | $19M | $24M | · | $62M | $68M | $83M | · | $114M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $70.0K | $391.0K | $3M | · | $6M | |
| Prepaid Expense | $17M | $16M | $25M | $22M | $26M | $20M | $19M | $22M | $34M | $38M | · | $29M | $48M | $34M | · | $38M | |
| Current Assets | $333M | $410M | $472M | $506M | $523M | $565M | $603M | $662M | $783M | $903M | · | $1.14B | $1.22B | $1.33B | · | $1.46B | |
| PP&E (Net) | $157M | $163M | $168M | $177M | $186M | $198M | $204M | $211M | $211M | $196M | · | $202M | $294M | $314M | · | $188M | |
| PP&E (Gross) | $355M | $352M | $358M | $359M | $360M | $361M | $365M | $362M | $347M | $326M | · | $322M | $413M | $421M | · | $271M | |
| Accum. Depreciation | $198M | $189M | $191M | $182M | $173M | $163M | $161M | $151M | $136M | $130M | · | $121M | $118M | $107M | · | $83M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | $48M | $49M | $58M | $59M | $59M | $60M | $29M | |
| Intangibles | $44M | $49M | $57M | $62M | $66M | $69M | $73M | $80M | $91M | $77M | · | $100M | $105M | $109M | · | $48M | |
| Other Non-current Assets | $1M | $40M | $47M | $47M | $47M | $47M | $55M | $60M | $60M | $61M | · | $97M | $98M | $97M | · | $44M | |
| Total Assets | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Accounts Payable | $10M | $16M | $11M | $11M | $11M | $11M | $14M | $16M | $23M | $27M | · | $11M | $14M | $22M | · | $11M | |
| Current Liabilities | $73M | $80M | $96M | $115M | $97M | $116M | $107M | $114M | $166M | $169M | · | $168M | $163M | $192M | · | $125M | |
| Capital Leases | $404M | $411M | $417M | $423M | $429M | $435M | $439M | $446M | $452M | $234M | · | $404M | $411M | $404M | · | · | |
| Other Non-current Liabilities | $16M | $22M | $23M | $17M | $18M | $15M | $17M | $18M | $21M | $25M | · | $19M | $20M | $29M | · | $35M | |
| Total Liabilities | $570M | $590M | $611M | $629M | $618M | $646M | $661M | $683M | $792M | $594M | · | $774M | $788M | $810M | · | $431M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $206.0K | $202.0K | · | $198.0K | $196.0K | $194.0K | · | $165.0K | |
| Paid-in Capital | $6.70B | $6.67B | $6.66B | $6.63B | $6.60B | $6.58B | $6.56B | $6.53B | $6.51B | $6.45B | · | $6.33B | $6.28B | $6.21B | · | $5.67B | |
| Retained Earnings | $-6.28B | $-6.23B | $-6.15B | $-6.07B | $-5.99B | $-5.93B | $-5.84B | $-5.73B | $-5.67B | $-5.46B | · | $-5.08B | $-4.78B | $-4.60B | · | $-4.23B | |
| AOCI | $950.0K | $1M | $2M | $2M | $2M | $-850.0K | $-2M | $263.0K | $-2M | $-2M | · | $-3M | $-1M | $-2M | · | $-8M | |
| Stockholders' Equity | $420M | $443M | $509M | $560M | $613M | $647M | $716M | $798M | $833M | $987M | $1.10B | $1.25B | $1.50B | $1.61B | $1.74B | $1.43B | |
| Liabilities + Equity | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Shares Outstanding | 63,711,102 | 61,660,788 | 58,207,298 | 56,836,246 | 55,425,334 | 54,698,246 | 54,365,785 | 53,082,000 | 2,078,737,000 | 2,033,624,000 | 50,032,873 | 1,972,725,000 | 1,954,704,000 | 1,933,880,000 | 47,299,399 | 1,648,263,224 |
Fluxo de Caixa 12
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $13M | $14M | $14M | $16M | $15M | $16M | $17M | $17M | $13M | $13M | $21M | $18M | $19M | $16M | $8M | |
| Stock-based Comp | $8M | $16M | $21M | $18M | $22M | $17M | $21M | $14M | $37M | $41M | $43M | $53M | $61M | $73M | $108M | $563M | |
| Amort. of Intangibles | $4M | $4M | $5M | $5M | $4M | $4M | $5M | $5M | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $1M | |
| Restructuring | · | · | $706.0K | $2M | $4M | · | $-666.0K | $3M | $12M | · | · | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-44M | $-47M | $-48M | $-32M | $-40M | $-52M | $-42M | $-104M | $-84M | $-89M | $-58M | $-74M | $-74M | $-91M | $-105M | $-28M | |
| CapEx | $3M | $2M | $5.0K | $0 | $38.0K | $8M | $14M | $15M | $27M | $7M | $3M | $4M | $14M | $19M | $26M | $13M | |
| Investing Cash Flow | $11M | $23M | $95M | $-73M | $-64M | $-199M | $-13M | $-10M | $-27M | $-12M | $-47M | $-3M | $-11M | $-19M | $30M | $-46M | |
| Stock Issued | · | · | $9M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $16M | $-19.0K | $8M | $10M | $-98.0K | $-207.0K | $-203.0K | $-465.0K | $-226.0K | $-845.0K | $-632.0K | $-315.0K | $-1M | $-888.0K | $98M | $-280.0K | |
| Net Change in Cash | $-17M | $-24M | $55M | $-94M | $-104M | $-250M | $-56M | $-114M | $-111M | $-102M | $-105M | $-77M | $-87M | $-111M | $24M | $-75M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Free Cash Flow | · | $-49M | · | · | · | $-59M | · | · | · | $-96M | · | · | · | $-110M | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| Net Margin | -231.7% | -424.1% | · | -207.9% | -121.6% | -188.2% | · | -63.3% | -386.4% | -437.2% | · | -546.4% | -215.1% | -254.0% | · | -1007.6% | |
| Pretax Margin | -283.8% | -391.0% | · | -207.9% | -122.1% | -188.1% | · | -63.8% | -386.1% | -437.2% | · | -546.5% | -215.0% | -253.9% | · | -1007.7% | |
| EBITDA Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| ROA | -4.2% | -7.1% | · | -6.0% | -4.2% | -6.3% | · | -3.2% | -11.1% | -8.3% | · | -15.5% | -8.1% | -9.2% | · | -33.3% | |
| ROE | -9.0% | -15.2% | · | -11.9% | -8.3% | -11.1% | · | -5.5% | -18.6% | -12.8% | · | -22.5% | -11.4% | -12.9% | · | -44.8% | |
| ROIC | -14.0% | -16.1% | · | -16.1% | -10.6% | -13.8% | · | -6.9% | -26.8% | -18.0% | · | -22.9% | -12.2% | -13.4% | · | -45.5% |
Liquidez e Solvência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 5.2 | · | 4.4 | 5.4 | 4.9 | · | 5.8 | 4.7 | 5.3 | · | 6.8 | 7.5 | 6.9 | · | 11.7 | |
| Quick Ratio | 1.3 | 2.1 | · | 4.5 | 6.0 | 3.0 | · | 5.6 | 4.5 | 5.1 | · | 6.6 | 7.2 | 6.7 | · | 11.3 |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.8 | · | 1.7 | 2.4 | 1.9 | · | 2.1 | 1.3 | 0.7 | · | 0.6 | 0.7 | 0.6 | · | 0.8 |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $118M | $146M | · | $226M | $243M | $232M | · | $239M | $230M | $255M | · | $283M | $372M | $460M | · | $457M | |
| Net Income TTM | $-270M | $-315M | · | $-288M | $-425M | $-530M | · | $-742M | $-859M | $-847M | · | $-1.35B | $-1.72B | $-2.13B | · | $-2.03B | |
| Market Cap | $631M | $378M | · | $829M | $624M | $312M | · | $433M | $27.77B | $94.36B | · | $142.83B | $145.43B | $102.88B | · | $205.70B | |
| P/E | -1.9 | -1.2 | · | -2.7 | -1.4 | -0.6 | · | -0.5 | -1.0 | -4.8 | · | -10.6 | -72.9 | -40.9 | · | -98.3 | |
| P/S | 5.4 | 2.6 | · | 3.7 | 2.6 | 1.3 | · | 1.8 | 120.7 | 370.6 | · | 504.5 | 390.6 | 223.6 | · | 450.1 | |
| P/B | 1.5 | 0.9 | · | 1.5 | 1.0 | 0.5 | · | 0.5 | 33.3 | 95.6 | · | 114.0 | 96.7 | 64.0 | · | 143.4 | |
| P / Tangible Book | 1.7 | 1.0 | · | 1.7 | 1.1 | 0.5 | · | 0.6 | 37.4 | 109.5 | · | 130.5 | 108.6 | 71.4 | · | 151.5 | |
| P / Cash Flow | · | -8.1 | · | · | · | -6.1 | · | · | · | -1057.2 | · | · | · | -1135.8 | · | · | |
| P / FCF | · | -7.8 | · | · | · | -5.3 | · | · | · | -983.2 | · | · | · | -935.1 | · | · | |
| Earnings Yield | -53.6% | -86.6% | · | -36.4% | -71.9% | -180.9% | · | -182.1% | -103.7% | -21.0% | · | -9.4% | -1.4% | -2.4% | · | -1.0% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $170M | $227M | $251M | $478M | $314M |
| Margem Operacional % | -185.3% | -246.5% | -343.8% | -462.4% | — |
| Lucro líquido | $-313M | $-547M | $-893M | $-2.10B | $-1.83B |
| EPS Diluído | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 4.9 | 5.6 | 6.1 | 8.4 | — |
| Índice de Liquidez Seca | 4.7 | 5.4 | 5.9 | 8.1 | — |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-179M | $-382M | $-336M | $-304M | — |
Últimas notícias Notícias recentes mencionando esta empresa
- Here's the "Magnificent Seven" Stock Cathie Wood Is Piling Into Now
- Yahoo announces AI-powered experiences for Yahoo Finance and Yahoo Sports
- This Warren Buffett Stock Is Beating the S&P 500 in 2026
- Procurador-Geral da Califórnia processa sucessor da 23andMe por violação de dados de 2023
- Anúncios de kits de autocoleta de DNA banidos por serem enganosos
- Jim Cramer sobre BillionToOne: “Eu digo compre”
- Como uma queimadura solar inspirou um novo método de armazenamento de energia
- Fornecedores de Maconha Processados por Alegadamente Não Avisar Consumidores Sobre Riscos
- Em Alta 30% em 1 Mês, Zcash é uma Compra Melhor que Bitcoin?
- SCHQ vs. TLT: Mesmo DNA do Tesouro, Custo e Duração Muito Diferentes
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 204 declarantes · $269.0M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 39 (+13 vs trimestre anterior) | 17 (-11 vs trimestre anterior) | 65 (+23 vs trimestre anterior) | 35 (-12 vs trimestre anterior) | +6.2M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | $35.449.338 | 3.577.128 | 13,18% | Ações |
| Erste Asset Management GmbH | $25.902.147 | 2.536.939 | 9,63% | Ações |
| BAILLIE GIFFORD & CO | $23.701.242 | 2.391.649 | 8,81% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $20.685.074 | 2.087.293 | 7,69% | Ações |
| Anchorage Capital Group, L.L.C. | $17.306.457 | 1.746.363 | 6,43% | Ações |
| STATE STREET CORP | $14.591.187 | 1.472.370 | 5,43% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $10.292.812 | 1.038.369 | 3,83% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.293.628 | 937.803 | 3,46% | Ações |
| Allianz Asset Management GmbH | $7.787.258 | 785.798 | 2,90% | Ações |
| MILLENNIUM MANAGEMENT LLC | $6.329.279 | 638.676 | 2,35% | Ações |
| SB INVESTMENT ADVISERS (UK) LTD | $6.052.324 | 610.729 | 2,25% | Ações |
| Prescott Group Capital Management, L.L.C. | $5.369.684 | 541.845 | 2,00% | Ações |
| GOLDMAN SACHS GROUP INC | $5.364.154 | 541.287 | 1,99% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $5.349.973 | 539.856 | 1,99% | Ações |
| BANK OF AMERICA CORP /DE/ | $4.760.754 | 480.399 | 1,77% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.109.677 | 414.700 | 1,53% | Opção de compra |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.910.555 | 394.607 | 1,45% | Ações |
| EXCHANGE TRADED CONCEPTS, LLC | $3.555.540 | 358.783 | 1,32% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $3.480.392 | 351.200 | 1,29% | Ações |
| TUDOR INVESTMENT CORP ET AL | $3.326.886 | 335.710 | 1,24% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $3.097.598 | 312.573 | 1,15% | Ações |
| Coastal Bridge Advisors, LLC | $2.743.256 | 276.817 | 1,02% | Ações |
| BALANCE CAPITAL PARTNERS L.P. | $1.972.179 | 199.009 | 0,73% | Ações |
| ALGERT GLOBAL LLC | $1.784.395 | 180.060 | 0,66% | Ações |
| Susquehanna Portfolio Strategies, LLC | $1.746.449 | 176.231 | 0,65% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $1.637.935 | 165.281 | 0,61% | Ações |
| PEAK6 LLC | $1.619.294 | 163.400 | 0,60% | Opção de compra |
| CAXTON ASSOCIATES LLP | $1.532.552 | 154.647 | 0,57% | Ações |
| D. E. Shaw & Co., Inc. | $1.499.938 | 151.356 | 0,56% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1.387.400 | 140.000 | 0,52% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.297.219 | 130.900 | 0,48% | Opção de venda |
| CITADEL ADVISORS LLC | $1.233.973 | 124.518 | 0,46% | Ações |
| JPMORGAN CHASE & CO | $1.154.383 | 113.064 | 0,43% | Ações |
| a16z Capital Management, L.L.C. | $1.075.909 | 108.568 | 0,40% | Ações |
| CITADEL ADVISORS LLC | $1.073.253 | 108.300 | 0,40% | Opção de compra |
| Numerai GP LLC | $1.036.606 | 104.602 | 0,39% | Ações |
| AMERICAN CENTURY COMPANIES INC | $974.718 | 98.357 | 0,36% | Ações |
| WOLVERINE TRADING, LLC | $964.467 | 72.900 | 0,36% | Opção de compra |
| Ensign Peak Advisors, Inc | $931.332 | 93.979 | 0,35% | Ações |
| Bank of New York Mellon Corp | $818.843 | 82.628 | 0,30% | Ações |
| PANAGORA ASSET MANAGEMENT INC | $803.592 | 81.089 | 0,30% | Ações |
| MARSHALL WACE, LLP | $772.356 | 77.937 | 0,29% | Ações |
| Swiss National Bank | $744.865 | 75.163 | 0,28% | Ações |
| ALLSTATE CORP | $698.209 | 70.455 | 0,26% | Ações |
| Mariner, LLC | $667.488 | 67.359 | 0,25% | Ações |
| IEQ CAPITAL, LLC | $624.766 | 63.044 | 0,23% | Ações |
| ALLEN OPERATIONS LLC | $613.935 | 61.951 | 0,23% | Ações |
| RHUMBLINE ADVISERS | $610.615 | 61.617 | 0,23% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $609.079 | 61.461 | 0,23% | Ações |
| TWO SIGMA INVESTMENTS, LP | $599.099 | 60.454 | 0,22% | Ações |
| BROWN ADVISORY INC | $586.731 | 59.206 | 0,22% | Ações |
| BlackRock, Inc. | $526.895 | 53.168 | 0,20% | Ações |
| EDGEWOOD MANAGEMENT LLC | $495.500 | 50.000 | 0,18% | Ações |
| WOLVERINE TRADING, LLC | $492.156 | 37.200 | 0,18% | Opção de venda |
| Quadrature Capital Ltd | $456.732 | 46.088 | 0,17% | Ações |
| MORGAN STANLEY | $447.427 | 45.149 | 0,17% | Ações |
| Shay Capital LLC | $444.384 | 44.842 | 0,17% | Ações |
| LPL Financial LLC | $427.257 | 43.114 | 0,16% | Ações |
| CITIGROUP INC | $426.893 | 43.077 | 0,16% | Ações |
| JANE STREET GROUP, LLC | $414.238 | 41.800 | 0,15% | Opção de compra |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $387.709 | 39.123 | 0,14% | Ações |
| Casdin Capital, LLC | $361.646 | 36.493 | 0,13% | Ações |
| CITADEL ADVISORS LLC | $347.841 | 35.100 | 0,13% | Opção de venda |
| Dynamic Technology Lab Private Ltd | $347.000 | 34.996 | 0,13% | Ações |
| ALLIANCEBERNSTEIN L.P. | $342.005 | 55.792 | 0,13% | Ações |
| GROUP ONE TRADING LLC | $326.138 | 32.910 | 0,12% | Ações |
| AlphaQuest LLC | $309.788 | 37.279 | 0,12% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $301.532 | 30.427 | 0,11% | Ações |
| Welch & Forbes LLC | $297.300 | 30.000 | 0,11% | Ações |
| MetLife Investment Management, LLC | $285.111 | 28.770 | 0,11% | Ações |
| AXQ CAPITAL, LP | $262.387 | 26.477 | 0,10% | Ações |
| BARCLAYS PLC | $258.919 | 26.127 | 0,10% | Ações |
| IMC-Chicago, LLC | $240.922 | 24.311 | 0,09% | Ações |
| Man Group plc | $239.901 | 24.208 | 0,09% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $238.425 | 24.059 | 0,09% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $222.975 | 22.500 | 0,08% | Ações |
| Russell Investments Group, Ltd. | $222.885 | 22.491 | 0,08% | Ações |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $217.356 | 21.933 | 0,08% | Ações |
| Modera Wealth Management, LLC | $216.316 | 21.828 | 0,08% | Ações |
| MARTINGALE ASSET MANAGEMENT L P | $209.062 | 21.096 | 0,08% | Ações |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $203.116 | 22.345 | 0,08% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $189.123 | 30.852 | 0,07% | Ações |
| Walleye Capital LLC | $188.944 | 19.066 | 0,07% | Ações |
| Invesco Ltd. | $186.209 | 18.790 | 0,07% | Ações |
| Trexquant Investment LP | $178.420 | 18.004 | 0,07% | Ações |
| SIMPLEX TRADING, LLC | $178.330 | 17.995 | 0,07% | Ações |
| Comprehensive Financial Management LLC | $174.971 | 17.656 | 0,07% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $172.474 | 17.404 | 0,06% | Ações |
| Boston Standard Wealth Management, LLC | $164.995 | 15.165 | 0,06% | Ações |
| DEUTSCHE BANK AG\ | $163.763 | 16.525 | 0,06% | Ações |
| Creative Planning | $156.974 | 15.840 | 0,06% | Ações |
| Vanguard Global Advisers, LLC | $155.904 | 15.732 | 0,06% | Ações |
| Squarepoint Ops LLC | $155.478 | 15.689 | 0,06% | Ações |
| MERCER GLOBAL ADVISORS INC /ADV | $153.664 | 15.506 | 0,06% | Ações |
| ExodusPoint Capital Management, LP | $148.343 | 14.969 | 0,06% | Ações |
| Police & Firemen's Retirement System of New Jersey | $146.420 | 14.775 | 0,05% | Ações |
| Entropy Technologies, LP | $138.423 | 13.968 | 0,05% | Ações |
| Green Alpha Advisors, LLC | $134.241 | 13.546 | 0,05% | Ações |
| VANGUARD GROUP INC | $130.733 | 15.732 | 0,05% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $127.690 | 12.885 | 0,05% | Ações |
Executivos da empresa 17 insiders · 5 diretores · 13 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Jason R Kelly | Chief Executive Officer & Founder | 28 de Julho de 2026 A | 3.894.680 | 0 | 0 | $0 |
| Steven P. Coen | Chief Financial Officer | 16 de Julho de 2026 M | 51.438 | 0 | 1 | $-5.941 |
| Mark E. Dmytruk | Chief Financial Officer | 20 de Maio de 2025 M | 46.226 | 0 | 0 | $0 |
| Reshma P. Shetty | President & Founder | 28 de Julho de 2026 A | 12.374.544 | 0 | 0 | $0 |
| Marie E. Fallon | Chief Accounting Officer | 1 de Maio de 2023 M | 183.010 | 0 | 0 | $0 |
| Sri Kosuri | Conselheiro | 11 de Junho de 2026 A | 24.067 | 0 | 0 | $0 |
| Ross Fubini | Conselheiro | 11 de Junho de 2026 A | 10.822 | 0 | 0 | $0 |
| Christian O Henry | Conselheiro | 11 de Junho de 2026 A | 24.310 | 0 | 2 | $-219.800 |
| Harry Sloan | Conselheiro | 11 de Junho de 2026 A | 271.418 | 0 | 0 | $0 |
| Shyam Sankar | Conselheiro | 12 de Junho de 2025 A | 72.372 | 0 | 0 | $0 |
| Kathy Hopinkah Hannan | Conselheiro | 11 de Junho de 2025 M | 15.003 | 0 | 0 | $0 |
| Myrtle S Potter | Conselheiro | 11 de Junho de 2025 M | 10.822 | 0 | 0 | $0 |
| Arie Belldegrun | Conselheiro | 13 de Junho de 2024 A | 194.925 | 0 | 0 | $0 |
| Reshma Kewalramani | Conselheiro | 12 de Junho de 2024 M | 186.002 | 0 | 0 | $0 |
| Marijn E Dekkers | Conselheiro | 12 de Junho de 2024 M | 386.480 | 0 | 0 | $0 |
| Eagle Equity Partners III, LLC | Conselheiro | 16 de Setembro de 2021 D | 31.590.948 | 0 | 0 | $0 |
| Barry Canton | Detentor de 10% | 28 de Julho de 2026 A | 12.374.544 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 4 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Reshma P. Shetty, Barry Canton | 14 de Fevereiro de 2025 | 9,50% | Emenda | — | SEC |
| Jason Kelly ×4 declarações | 14 de Fevereiro de 2024 | — | Declaração inicial | — | SEC |
| Reshma Shetty, Bartholomew Canton ×4 declarações | 14 de Fevereiro de 2024 | — | Declaração inicial | — | SEC |
| VIKING GLOBAL INVESTORS LP, VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. ANDREAS HALVORSEN, DAVID C. OTT, ROSE S. SHABET ×3 declarações | 4 de Março de 2022 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 33 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 0,84% | 321.721 NS | 30 de Abril de 2026 | N-PORT |
| IDNA · iShares Trust | 0,44% | 101.324 SH | 8 de Agosto de 2026 | Diário |
| IWC · iShares Trust | 0,09% | 161.981 SH | 8 de Agosto de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 187.206 SH | 8 de Agosto de 2026 | Diário |
| IBB · iShares Trust | 0,03% | 368.167 SH | 8 de Agosto de 2026 | Diário |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,03% | 91.425 NS | 31 de Maio de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 41.498 SH | 8 de Agosto de 2026 | Diário |
| IWN · iShares Trust | 0,03% | 442.118 SH | 8 de Agosto de 2026 | Diário |
| IWM · iShares Trust | 0,01% | 1.226.249 SH | 8 de Agosto de 2026 | Diário |
| RSSL · Global X Funds | 0,01% | 18.139 NS | 30 de Abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 549.889 SH | 8 de Agosto de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 274.008 SH | 8 de Agosto de 2026 | Diário |
| ITWO · ProShares Trust | 0,01% | 2.005 NS | 31 de Maio de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,01% | 112.735 SH | 8 de Agosto de 2026 | Diário |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 210.534 NS | 31 de Maio de 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 1.567 NS | 31 de Maio de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 16.982 NS | 30 de Abril de 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1.584 NS | 31 de Maio de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.081 NS | 31 de Maio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 4.528 NS | 30 de Abril de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 40 NS | 31 de Maio de 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,00% | 252 NS | 30 de Abril de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 19.123 NS | 30 de Abril de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 22.130 SH | 8 de Agosto de 2026 | Diário |
| ITOT · iShares Trust | 0,00% | 66.432 SH | 8 de Agosto de 2026 | Diário |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 26.477 NS | 31 de Maio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3.795 NS | 30 de Abril de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 584 NS | 30 de Abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 1.182 NS | 30 de Abril de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.489.851 SH | 8 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.264 SH | 8 de Agosto de 2026 | Diário |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 504 NS | 31 de Maio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1.232 NS | 30 de Abril de 2026 | N-PORT |